Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing

INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers and poses a challenge to the treating clinician. With the emergence of genomic profiling technologies, circulating tumor DNA (ctDNA) is increasingly recognized as a versatile biomarker for risk stratification...

Descripción completa

Detalles Bibliográficos
Autores principales: Balendran-Braun, Sukirthini, Kieler, Markus, Liebmann-Reindl, Sandra, Unseld, Matthias, Bianconi, Daniela, W Prager, Gerald, Streubel, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357621/
https://www.ncbi.nlm.nih.gov/pubmed/34393517
http://dx.doi.org/10.2147/CMAR.S308029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357621/
https://www.ncbi.nlm.nih.gov/pubmed/34393517
http://dx.doi.org/10.2147/CMAR.S308029

Ejemplares similares